Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-08-13 10:27:48 UTC |
---|
Update Date | 2022-07-14 23:24:51 UTC |
---|
HMDB ID | HMDB0004080 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Anandamide |
---|
Description | Anandamide, also known as arachidonoylethanolamide (AEA), is a highly potent endogenous agonist of the cannabinoid CB1 and CB2 receptors. CB1 receptors are predominantly found in the central nervous system (CNS) where they mainly mediate the psychotropic effects of tetrahydrocannabinol (THC) and endocannabinoids, whereas the expression of the CB2 receptor is thought to be restricted to cells of the immune system. It was suggested that AEA might inhibit tumour cell proliferation or induce apoptosis independently of CB1 and CB2 receptors, via interaction with the type 1 vanilloid receptor (VR1). VR1 is an ion channel expressed almost exclusively by sensory neurons, activated by pH, noxious heat (> 48-degree centigrade), and plant toxins and is thought to play an important role in nociception. Cervical cancer cells are sensitive to AEA-induced apoptosis via VR1 that is aberrantly expressed in vitro and in vivo while CB1 and CB2 receptors play a protective role. (PMID: 15047233 ). Novel prostaglandins (prostaglandin glycerol esters and prostaglandin ethanolamides) are COX-2 oxidative metabolites of endogenous cannabinoids (such as anandamide). Recent evidence suggests that these new types of prostaglandins are likely novel signalling mediators involved in synaptic transmission and plasticity (PMID: 16957004 ). |
---|
Structure | CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO InChI=1S/C22H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23-20-21-24/h6-7,9-10,12-13,15-16,24H,2-5,8,11,14,17-21H2,1H3,(H,23,25)/b7-6-,10-9-,13-12-,16-15- |
---|
Synonyms | Value | Source |
---|
(5Z,8Z,11Z,14Z)-N-(2-Hydroxyethyl)-5,8,11,14-eicosatetraenamide | ChEBI | (all-Z)-N-(2-Hydroxyethyl)-5,8,11,14-eicosatetraenamide | ChEBI | AEA | ChEBI | Anandamide (20.4, N-6) | ChEBI | Anandamide(20:4, N-6) | ChEBI | Arachidonic acid N-(hydroxyethyl)amide | ChEBI | Arachidonoyl ethanolamide | ChEBI | Arachidonylethanolamide | ChEBI | N-(2-Hydroxyethyl)anachidonamide | ChEBI | N-(5Z,8Z,11Z,14Z-Eicosatetraenoyl)-ethanolamine | ChEBI | N-(5Z,8Z,11Z,14Z-Icosatetraenoyl)-ethanolamide | ChEBI | N-Arachidonoyl ethanolamine | ChEBI | N-Arachidonoyl-2-hydroxyethylamide | ChEBI | N-Arachidonoylethanolamine | ChEBI | Arachidonate N-(hydroxyethyl)amide | Generator | N-(5Z,8Z,11Z,14Z-Eicosatetraenoyl) ethanolamine | HMDB | 5,8,11,14-Eicosatetraenoylethanolamide | HMDB | N-(2-Hydroxyethyl)-5,8,11,14-eicosatetraenamide (all-Z) | HMDB | N-(2-Hydroxyethyl)arachidonamide | HMDB | Anandamide (20.4,N-6) | HMDB | Arachidonoylethanolamide | HMDB | N-Arachidonoylethanolamide | HMDB | Anandamide | MeSH | N-(2-Hydroxyethyl)arachidonylamide | HMDB | N-Arachidonylethanolamide | HMDB | N-Arachidonylethanolamine | HMDB | AEA(22:6) | HMDB | Acylethanolamine 22:6 | HMDB |
| Show more...
---|
Chemical Formula | C22H37NO2 |
---|
Average Molecular Weight | 347.5347 |
---|
Monoisotopic Molecular Weight | 347.282429433 |
---|
IUPAC Name | (5Z,8Z,11Z,14Z)-N-(2-hydroxyethyl)icosa-5,8,11,14-tetraenamide |
---|
Traditional Name | anandamide |
---|
CAS Registry Number | 94421-68-8 |
---|
SMILES | CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO |
---|
InChI Identifier | InChI=1S/C22H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23-20-21-24/h6-7,9-10,12-13,15-16,24H,2-5,8,11,14,17-21H2,1H3,(H,23,25)/b7-6-,10-9-,13-12-,16-15- |
---|
InChI Key | LGEQQWMQCRIYKG-DOFZRALJSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as n-acylethanolamines. N-acylethanolamines are compounds containing an N-acyethanolamine moiety, which is characterized by an acyl group is linked to the nitrogen atom of ethanolamine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic nitrogen compounds |
---|
Class | Organonitrogen compounds |
---|
Sub Class | Amines |
---|
Direct Parent | N-acylethanolamines |
---|
Alternative Parents | |
---|
Substituents | - N-acylethanolamine
- Fatty amide
- N-acyl-amine
- Fatty acyl
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Alcohol
- Organooxygen compound
- Primary alcohol
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Carbonyl group
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Anandamide,1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO[Si](C)(C)C | 2863.5 | Semi standard non polar | 33892256 | Anandamide,1TMS,isomer #2 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N(CCO)[Si](C)(C)C | 2799.1 | Semi standard non polar | 33892256 | Anandamide,2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N(CCO[Si](C)(C)C)[Si](C)(C)C | 2853.6 | Semi standard non polar | 33892256 | Anandamide,2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N(CCO[Si](C)(C)C)[Si](C)(C)C | 2908.6 | Standard non polar | 33892256 | Anandamide,2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N(CCO[Si](C)(C)C)[Si](C)(C)C | 2886.9 | Standard polar | 33892256 | Anandamide,1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO[Si](C)(C)C(C)(C)C | 3111.6 | Semi standard non polar | 33892256 | Anandamide,1TBDMS,isomer #2 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N(CCO)[Si](C)(C)C(C)(C)C | 3049.8 | Semi standard non polar | 33892256 | Anandamide,2TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N(CCO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3350.0 | Semi standard non polar | 33892256 | Anandamide,2TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N(CCO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3257.3 | Standard non polar | 33892256 | Anandamide,2TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N(CCO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2940.0 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Anandamide GC-EI-TOF (Non-derivatized) | splash10-0gb9-1910000000-79c55260280d43c9a900 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Anandamide GC-EI-TOF (Non-derivatized) | splash10-0fs7-5900000000-75831770c51e1d2f739d | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Anandamide GC-EI-TOF (Non-derivatized) | splash10-0gb9-1910000000-79c55260280d43c9a900 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Anandamide GC-EI-TOF (Non-derivatized) | splash10-0fs7-5900000000-75831770c51e1d2f739d | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Anandamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-02a5-7493000000-c585906fb5c6d8aa4ff3 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Anandamide GC-MS (1 TMS) - 70eV, Positive | splash10-0fki-9353100000-6c635dea7003727f3b83 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Anandamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Anandamide 10V, Positive-QTOF | splash10-0002-1029000000-acb4551dcc9e3f6e05dd | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Anandamide 40V, Positive-QTOF | splash10-03xr-9000000000-45148e922a9fd54fabf5 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Anandamide 20V, Positive-QTOF | splash10-03di-9230000000-c1ae6b0473246ef09b54 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Anandamide 40V, Positive-QTOF | splash10-03xr-9000000000-100fb9f29334308faa9d | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Anandamide 10V, Positive-QTOF | splash10-01ot-5149000000-76b6af47eca436d3e5ec | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Anandamide 20V, Positive-QTOF | splash10-03dl-9131000000-069d65af4be10e925d42 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Anandamide 40V, Positive-QTOF | splash10-03dl-9230000000-3590307e1cf3aab76689 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Anandamide 10V, Negative-QTOF | splash10-0002-0009000000-004521084d25577be5fe | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Anandamide 20V, Negative-QTOF | splash10-01r2-5019000000-1c63bb1751f58bf91f0c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Anandamide 40V, Negative-QTOF | splash10-0006-9010000000-161a34c3d66caea4a293 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Anandamide 10V, Positive-QTOF | splash10-01ot-9328000000-b4562c25b6933ac7a7ba | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Anandamide 20V, Positive-QTOF | splash10-03dl-9000000000-4d45bc23e3d763bd083b | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Anandamide 40V, Positive-QTOF | splash10-03dl-9100000000-ed96624588d13e15a5bf | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Anandamide 10V, Negative-QTOF | splash10-0002-0009000000-a3f88dce43caba26e0b0 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Anandamide 20V, Negative-QTOF | splash10-0002-5129000000-5f007c24785520e490c5 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Anandamide 40V, Negative-QTOF | splash10-052f-9010000000-868cfda7283947a9fbc4 | 2021-09-23 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.008 +/- 0.016 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 2.99 +/- 5.39 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 3.12 +/- 1.2 uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.01165 +/- 0.00753 uM | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.00255 +/- 0.00178 uM | Adult (>18 years old) | Both | Epilepsy | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Epilepsy |
---|
- Romigi A, Bari M, Placidi F, Marciani MG, Malaponti M, Torelli F, Izzi F, Prosperetti C, Zannino S, Corte F, Chiaramonte C, Maccarrone M: Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy. Epilepsia. 2010 May;51(5):768-72. doi: 10.1111/j.1528-1167.2009.02334.x. Epub 2009 Oct 8. [PubMed:19817812 ]
|
|
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB023303 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 4445241 |
---|
KEGG Compound ID | C11695 |
---|
BioCyc ID | CPD-7598 |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Anandamide |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 5281969 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 2700 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | C11695 |
---|
MarkerDB ID | MDB00000439 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Qi, Longwu; Meijler, Michael M.; Lee, Sang-Hyeup; Sun, Chengzao; Janda, Kim D. Solid-Phase Synthesis of Anandamide Analogues. Organic Letters (2004), 6(10), 1673-1675. |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, Nguyen DN, Richardson JM, Riggin RM, Koppel GA, Paul SM, Becker GW: Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett. 1996 Sep 16;393(2-3):231-5. [PubMed:8814296 ]
- Contassot E, Tenan M, Schnuriger V, Pelte MF, Dietrich PY: Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1. Gynecol Oncol. 2004 Apr;93(1):182-8. [PubMed:15047233 ]
- Sang N, Chen C: Lipid signaling and synaptic plasticity. Neuroscientist. 2006 Oct;12(5):425-34. [PubMed:16957004 ]
- Anton M, Rodriguez-Gonzalez A, Rodriguez-Rojo IC, Pastor A, Correas A, Serrano A, Ballesta A, Alen F, Gomez de Heras R, de la Torre R, Rodriguez de Fonseca F, Orio L: Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women. Addict Biol. 2018 Nov;23(6):1242-1250. doi: 10.1111/adb.12580. Epub 2017 Nov 27. [PubMed:29178411 ]
|
---|